Cargando…
Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
Classical pharmacology has been the basis for the discovery of new chemical entities with therapeutic effects for decades. In natural product research, compounds are generally tested in vivo only after full in vitro characterization. However drug screening using this methodology is expensive, time-c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266807/ https://www.ncbi.nlm.nih.gov/pubmed/25516845 http://dx.doi.org/10.1016/j.ijpddr.2014.07.001 |
_version_ | 1782349062654132224 |
---|---|
author | Simoes-Pires, Claudia Hostettmann, Kurt Haouala, Amina Cuendet, Muriel Falquet, Jacques Graz, Bertrand Christen, Philippe |
author_facet | Simoes-Pires, Claudia Hostettmann, Kurt Haouala, Amina Cuendet, Muriel Falquet, Jacques Graz, Bertrand Christen, Philippe |
author_sort | Simoes-Pires, Claudia |
collection | PubMed |
description | Classical pharmacology has been the basis for the discovery of new chemical entities with therapeutic effects for decades. In natural product research, compounds are generally tested in vivo only after full in vitro characterization. However drug screening using this methodology is expensive, time-consuming and very often inefficient. Reverse pharmacology, also called bedside-to-bench, is a research approach based on the traditional knowledge and relates to reversing the classical laboratory to clinic pathway to a clinic to laboratory practice. It is a trans-disciplinary approach focused on traditional knowledge, experimental observations and clinical experiences. This paper is an overview of the reverse pharmacology approach applied to the decoction of Argemone mexicana, used as an antimalarial traditional medicine in Mali. A. mexicana appeared as the most effective traditional medicine for the treatment of uncomplicated falciparum malaria in Mali, and the clinical efficacy of the decoction was comparable to artesunate–amodiaquine as previously published. Four stages of the reverse pharmacology process will be described here with a special emphasis on the results for stage 4. Briefly, allocryptopine, protopine and berberine were isolated through bioguided fractionation, and had their identity confirmed by spectroscopic analysis. The three alkaloids showed antiparasitic activity in vitro, of which allocryptopine and protopine were selective towards Plasmodiumfalciparum. Furthermore, the amount of the three active alkaloids in the decoction was determined by quantitative NMR, and preliminary in vivo assays were conducted. On the basis of these results, the reverse pharmacology approach is discussed and further pharmacokinetic studies appear to be necessary in order to determine whether these alkaloids can be considered as phytochemical markers for quality control and standardization of an improved traditional medicine made with this plant. |
format | Online Article Text |
id | pubmed-4266807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-42668072014-12-16 Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana Simoes-Pires, Claudia Hostettmann, Kurt Haouala, Amina Cuendet, Muriel Falquet, Jacques Graz, Bertrand Christen, Philippe Int J Parasitol Drugs Drug Resist Invited Article Classical pharmacology has been the basis for the discovery of new chemical entities with therapeutic effects for decades. In natural product research, compounds are generally tested in vivo only after full in vitro characterization. However drug screening using this methodology is expensive, time-consuming and very often inefficient. Reverse pharmacology, also called bedside-to-bench, is a research approach based on the traditional knowledge and relates to reversing the classical laboratory to clinic pathway to a clinic to laboratory practice. It is a trans-disciplinary approach focused on traditional knowledge, experimental observations and clinical experiences. This paper is an overview of the reverse pharmacology approach applied to the decoction of Argemone mexicana, used as an antimalarial traditional medicine in Mali. A. mexicana appeared as the most effective traditional medicine for the treatment of uncomplicated falciparum malaria in Mali, and the clinical efficacy of the decoction was comparable to artesunate–amodiaquine as previously published. Four stages of the reverse pharmacology process will be described here with a special emphasis on the results for stage 4. Briefly, allocryptopine, protopine and berberine were isolated through bioguided fractionation, and had their identity confirmed by spectroscopic analysis. The three alkaloids showed antiparasitic activity in vitro, of which allocryptopine and protopine were selective towards Plasmodiumfalciparum. Furthermore, the amount of the three active alkaloids in the decoction was determined by quantitative NMR, and preliminary in vivo assays were conducted. On the basis of these results, the reverse pharmacology approach is discussed and further pharmacokinetic studies appear to be necessary in order to determine whether these alkaloids can be considered as phytochemical markers for quality control and standardization of an improved traditional medicine made with this plant. Elsevier 2014-07-30 /pmc/articles/PMC4266807/ /pubmed/25516845 http://dx.doi.org/10.1016/j.ijpddr.2014.07.001 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Invited Article Simoes-Pires, Claudia Hostettmann, Kurt Haouala, Amina Cuendet, Muriel Falquet, Jacques Graz, Bertrand Christen, Philippe Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana |
title | Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana |
title_full | Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana |
title_fullStr | Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana |
title_full_unstemmed | Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana |
title_short | Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana |
title_sort | reverse pharmacology for developing an anti-malarial phytomedicine. the example of argemone mexicana |
topic | Invited Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266807/ https://www.ncbi.nlm.nih.gov/pubmed/25516845 http://dx.doi.org/10.1016/j.ijpddr.2014.07.001 |
work_keys_str_mv | AT simoespiresclaudia reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana AT hostettmannkurt reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana AT haoualaamina reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana AT cuendetmuriel reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana AT falquetjacques reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana AT grazbertrand reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana AT christenphilippe reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana |